🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Timing of Specific Exercise Therapy After Breast Cancer Surgery: Early Versus Delayed Initiation

RecruitingNAAges 18 Years - 65 YearsAllAl Hayah University In Cairo
NCT06918184 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This single-center, parallel-group randomized controlled trial (RCT) will compare two timings for initiating specific exercise therapy after breast cancer surgery. The study tests whether early initiation (within the first postoperative week) versus delayed initiation (at 3 weeks postoperative) results in superior upper limb function at 6 months as measured by the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. Secondary outcomes include pain intensity (Visual Analog Scale, VAS) and wound-related complications such as drainage time and hematoma incidence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women aged 18-65 years. * Scheduled to undergo breast cancer surgery with axillary node dissection. * At risk for upper limb morbidity based on preoperative assessment. * Able to provide informed consent and complete study questionnaires. * Willing and able to attend scheduled physiotherapy sessions and follow-up evaluations. Exclusion Criteria: * Diagnosis of recurrent or metastatic breast cancer. * Concurrent participation in another rehabilitation intervention or clinical trial. * Severe comorbidities (e.g., uncontrolled cardiovascular disease, severe orthopedic conditions) that preclude safe participation. * History of previous shoulder surgery or chronic upper extremity musculoskeletal disorders unrelated to breast cancer treatment. * Inability to understand or complete study materials in English. * Pregnancy or lactation.
💊

What it tests

  • Specific Exercise Therapy
📍

Where

1 site
Faculty of Physical Therapy, Al Hayah University
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy